resTORbio to Present at the 9th Annual Leerink Partners Global Healthcare Conference
February 20 2020 - 8:00AM
resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical
company developing innovative medicines that target the biology of
aging to prevent or treat aging-related diseases, today announced
that the company will present at the 9th Annual Leerink Partners
Global Healthcare Conference in New York City on Thursday, February
27, 2019 at 10:00 AM ET.
A live audio webcast of the presentation can be accessed on the
Investors section of resTORbio’s website at
http://ir.restorbio.com/investors. An archived replay will be
available for 30 days following the presentation.
About resTORbioresTORbio, Inc. is a
clinical-stage biopharmaceutical company developing innovative
medicines that target the biology of aging to treat aging-related
diseases. resTORbio’s lead program selectively inhibits TORC1, an
evolutionarily conserved pathway that contributes to the decline in
function of aging organ systems, including neurologic function.
Learn more about resTORbio, Inc. at www.resTORbio.com.
Investor ContactLauren StivalStern Investor
Relations, Inc.212-362-1200lauren.stival@sternir.com
Media ContactKaren
SharmaMacDougall781-235-3060ksharma@macbiocom.com
resTORbio (NASDAQ:TORC)
Historical Stock Chart
From Mar 2024 to Apr 2024
resTORbio (NASDAQ:TORC)
Historical Stock Chart
From Apr 2023 to Apr 2024
